Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biotricity Inc (NQ: BTCY )

0.6735 +0.0213 (+3.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Biotricity Inc

< Previous 1 2 3 Next >
Biotricity CEO Speaks to the Future of AI and its Contributions to Healthcare
Via ACCESSWIRE
Biotricity Reaches $13M Revenue Run Rate in April 2023 on Accelerating Growth
Via ACCESSWIRE
Biotricity's Founder & CEO Waqaas Al-Siddiq to Present at World Heart Summit May 19-21 in Geneva, Switzerland
Via ACCESSWIRE
New Report Reveals Medtech Company Biotricity Decreased Patient Spending By Millions While Delivering Life-Saving Products
Via ACCESSWIRE
Biotricity Reaches $12M Revenue Run Rate in March with Promising Future Growth Ahead
Via ACCESSWIRE
Leading Medical Biometric Firm Biotricity Releases First Corporate Impact Report
Via ACCESSWIRE
Medical Biometric Firm Biotricity Reshaping Market Through Pioneering Innovation
Via ACCESSWIRE
Biotricity Surpasses $10 Million in Annual Revenue Run Rate
Via ACCESSWIRE
Biotricity Provides Updates on its Operational and Expansion Strategy
Via ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Second Quarter
Via ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 Third Quarter
Via ACCESSWIRE
Biotricity To Host Fiscal 2023 Third Quarter Financial Results Call on February 14th at 4:30pm ET
Via ACCESSWIRE
Biotricity Selected to Present its Work on AI Enabled Stroke Prediction in CKD Patients at the 2nd Annual Innovation Showcase during the American Stroke Association 2023 International Stroke Conference
Via ACCESSWIRE
Biotricity Signs Distribution Agreement With Top 5 Distributor for its Cardiac Monitoring Solutions
Via ACCESSWIRE
Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET
Via ACCESSWIRE
Biotricity's Bioheart Named to TIME's List of The Best Inventions of 2022
Via ACCESSWIRE
Biotricity Surpasses 2 billion Recorded and Analyzed Heartbeats for Atrial Fibrillation (AFib)
Via ACCESSWIRE
Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023
Via ACCESSWIRE
Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth
Via ACCESSWIRE
Biotricity Signs Distribution Agreement to Expand Access for its Cardiac Monitoring Solutions
Via ACCESSWIRE
Biotricity to Host Fiscal 2023 Second Quarter Financial Results on November 14th at 4:30 PM ET
Via ACCESSWIRE
Biotricity Launches Cardiac Disease Management Solution Following 2 Successful Pilots with Oklahoma & Kentucky Clinics
Via ACCESSWIRE
Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th
Via ACCESSWIRE
Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure
Via ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2023 First Quarter
Via ACCESSWIRE
Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET
Via ACCESSWIRE
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year
Company Reports Record Revenue and Improved Margins 
From Biotricity, Inc.
Via AccessWire
Exposures COVID-19
Biotricity to Join Russell Microcap(R) Index
REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the... 
From Biotricity, Inc.
Via AccessWire
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present... 
From Biotricity, Inc.
Via AccessWire
Biotricity Issues Shareholder Update
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
From Biotricity, Inc.
Via AccessWire
Exposures COVID-19
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.